Comparison
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 vs 3q26q28 Deletion Syndrome C6010434
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Fetoplacental Androgens Excess and 3q26q28 Deletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
A condition where the placenta and fetus together produce excess androgens, affecting an XX embryo's development. It is present at birth. Multidisciplinary care helps manage physical and hormonal aspects.
3q26q28 Deletion Syndrome C6010434
A genetic condition involving deletion of part of chromosome 3q26q28, typically causing developmental delays, growth issues, and multiple congenital differences.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
Variable
3q26q28 Deletion Syndrome C6010434
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
severe
3q26q28 Deletion Syndrome C6010434
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
Chronic
3q26q28 Deletion Syndrome C6010434
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
No
3q26q28 Deletion Syndrome C6010434
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
reproductive
3q26q28 Deletion Syndrome C6010434
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
endocrine
3q26q28 Deletion Syndrome C6010434
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-fetoplacental-androgens-excess-C5679876 and 3q26q28-deletion-syndrome-C6010434 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 | 3q26q28 Deletion Syndrome C6010434 | Discriminating power |
|---|---|---|---|
| Genital appearance at birth | XX embryo may show androgen-related atypical genital development. | Genital difference is not the defining feature in the supplied description. | High |
| Development and growth | Primary issue is hormonal influence on sex development, not a stated global developmental syndrome. | Typically associated with developmental delay, growth issues, and multiple congenital differences. | High |
| Cause suggested by evaluation | Points toward excess androgen exposure from fetus and placenta. | Points toward deletion involving chromosome 3q26q28. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 when
XX infant with androgen-related atypical genitalia
The supplied mechanism is excess fetoplacental androgen affecting an XX embryo.
Moderate
Endocrine evaluation suggests prenatal androgen excess
Category is endocrine rather than a chromosomal deletion.
Moderate
No established chromosomal diagnosis explains the presentation
Consider this pathway while genetic causes remain under evaluation.
Low
Choose 3q26q28 Deletion Syndrome C6010434 when
Developmental delay with growth concerns
These features are described for 3q26q28 deletion syndrome.
Moderate
Multiple congenital differences suggest a syndrome
The condition is a congenital genetic deletion rather than an isolated endocrine process.
Moderate
Genetic testing identifies the relevant deletion
A confirmed 3q26q28 deletion supports this diagnosis over androgen excess.
High
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 | 3q26q28 Deletion Syndrome C6010434 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal microarray | Expected chromosomal sex is 46,XX; deletion is not the stated cause. | May identify deletion of chromosome 3q26q28. | Genetic results distinguish a chromosomal syndrome from an endocrine mechanism. |
| Endocrine assessment | Evaluation focuses on androgen exposure and related hormonal effects. | No specific endocrine pattern is established by the source. | Abnormal hormone results are not themselves a diagnosis and need clinical correlation. |
| Clinical dysmorphology review | Emphasis is on sex development rather than a described multisystem pattern. | May support a congenital syndrome when multiple differences are present. | Pattern recognition guides testing but does not replace confirmatory evaluation. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
- Outcome
- Chronic condition with management focused on physical and hormonal needs; exact outcome is not established.
- Factors
- Timing of recognition, hormonal findings, and access to multidisciplinary care.
3q26q28 Deletion Syndrome C6010434
- Outcome
- Chronic congenital condition with variable developmental and growth effects; exact outcome is not established.
- Factors
- Extent of deletion, associated congenital differences, and developmental support.
Time frame: Both are present from early development and may need long-term follow-up.
Confirmed diagnosis, associated findings, and individualized supportive care influence course.
Complications comparison
| Complication | Presentation |
|---|---|
| Hormonal and physical effects | May require coordinated management of physical and hormonal aspects. Hormonal complications are not specified in the source. Care needs should be individualized; exact complications are not established here. |
| Developmental impact | Global developmental delay is not stated as a core feature. Developmental delay is typically described. Severity and functional outcome vary and are not quantified. |
| Congenital differences | Main described difference concerns sex development. Multiple congenital differences may occur. The range of anomalies is not fully specified by the supplied data. |
Patient education highlights
- HighDiagnosis is specialist-led
These are distinct congenital conditions; testing and interpretation should be guided by qualified clinicians.
- HighSupportive multidisciplinary care
Endocrine, genetics, and developmental specialists may be involved according to the confirmed diagnosis.
- MediumAvoid unsupported predictions
Available descriptions do not establish exact outcomes, laboratory cutoffs, or treatment doses.